Author

Yuezhong Zhang

University of MichiganORCID 0000-0002-8827-0114Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Cristina CastilloiD· 2 shared Nicholas J. RossiteriD· 2 shared Nupur Kanti DasiD· 2 shared Sumeet A. SolankiiD· 2 shared Yatrik Madhukar ShahiD· 2 shared Andrii BaliaiD· 1 shared Brandon CheniD· 1 shared Chesta JainiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Cristina CastilloORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCell MetabolismPeer-reviewedMay 27, 2026

Iron addicted colorectal cancers exploit Heme-Complex II axis to resist oxidative cell death

Chesta Jain, Muqit Essani, Roshan Kumar…·Yatrik Madhukar Shah

This study identifies a heme-SDH-CoQ axis that helps colorectal cancer cells resist iron-induced oxidative stress and cell death.

4 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCancer ResearchPeer-reviewedMay 19, 2025

Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer

Stephen L. DeAngelo, Liang Zhao, Sofia Dziechciarz…·Yatrik Madhukar Shah

This study recharacterizes RSL3 as a broad selenoprotein inhibitor, showing its potential as a therapeutic target for colorectal cancer by inducing ferroptosis.

39 citationstop 1%

humanproteomics

𝕏 PostBluesky